96 related articles for article (PubMed ID: 30115380)
1. Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion.
Lee JY; Kim JM; Jeong DS; Kim MH
Biochem Biophys Res Commun; 2018 Sep; 503(4):2924-2930. PubMed ID: 30115380
[TBL] [Abstract][Full Text] [Related]
2. HOXB5 Promotes the Proliferation and Invasion of Breast Cancer Cells.
Lee JY; Hur H; Yun HJ; Kim Y; Yang S; Kim SI; Kim MH
Int J Biol Sci; 2015; 11(6):701-11. PubMed ID: 25999793
[TBL] [Abstract][Full Text] [Related]
3. HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression.
Kim CY; Kim YC; Oh JH; Kim MH
Anticancer Res; 2021 Jul; 41(7):3409-3417. PubMed ID: 34230136
[TBL] [Abstract][Full Text] [Related]
4. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
[TBL] [Abstract][Full Text] [Related]
5. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer.
Li T; Lu H; Mukherjee D; Lahiri SK; Shen C; Yu L; Zhao J
Oncotarget; 2015 Aug; 6(25):21428-42. PubMed ID: 26025929
[TBL] [Abstract][Full Text] [Related]
6. Homeobox b5 (Hoxb5) regulates the expression of Forkhead box D3 gene (Foxd3) in neural crest.
Kam MK; Cheung M; Zhu JJ; Cheng WW; Sat EW; Tam PK; Lui VC
Int J Biochem Cell Biol; 2014 Oct; 55():144-52. PubMed ID: 25220476
[TBL] [Abstract][Full Text] [Related]
7. HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2.
Winnik S; Klinkert M; Kurz H; Zoeller C; Heinke J; Wu Y; Bode C; Patterson C; Moser M
Cardiovasc Res; 2009 Aug; 83(3):558-65. PubMed ID: 19403561
[TBL] [Abstract][Full Text] [Related]
8. HOXB5 promotes retinoblastoma cell migration and invasion via ERK1/2 pathway-mediated MMPs production.
Xu H; Zhao H; Yu J
Am J Transl Res; 2018; 10(6):1703-1712. PubMed ID: 30018711
[TBL] [Abstract][Full Text] [Related]
9. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
Yoon SO; Shin S; Lipscomb EA
Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
[TBL] [Abstract][Full Text] [Related]
11. miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5.
Gao X; Zhao H; Diao C; Wang X; Xie Y; Liu Y; Han J; Zhang M
Biochem Biophys Res Commun; 2018 Jan; 495(1):1074-1080. PubMed ID: 29170127
[TBL] [Abstract][Full Text] [Related]
12. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.
Selitrennik M; Lev S
Oncotarget; 2015 Sep; 6(26):22214-26. PubMed ID: 26084289
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
14. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.
Molli PR; Adam L; Kumar R
Clin Cancer Res; 2008 Oct; 14(19):6161-70. PubMed ID: 18829495
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
Li J; Zhang T; Yang F; He Y; Dai F; Gao D; Chen Y; Liu M; Yi Z
Br J Pharmacol; 2015 Aug; 172(15):3817-30. PubMed ID: 25884486
[TBL] [Abstract][Full Text] [Related]
17. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
18. [Involvement of epidermal growth factor receptor signaling pathway in tamoxifen resistance of MCF-7 cells].
Zhen LL; Zhu X; Zheng W; Wang XY; Wu ZY
Ai Zheng; 2006 Jul; 25(7):839-43. PubMed ID: 16831274
[TBL] [Abstract][Full Text] [Related]
19. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
20. miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer.
Guo J; Gong G; Zhang B
Sci Rep; 2018 Feb; 8(1):2073. PubMed ID: 29391441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
